Updated:
Green Cross LabCell Corporation
Green Cross LabCell Corporation is a biotech-focused family office with offices in San Francisco, Seoul, and Yongin, investing in healthcare and life...
Green Cross LabCell Corporation
Green Cross LabCell Corporation was established as an investment vehicle linked to the Green Cross group, a South Korean healthcare conglomerate founded in 1967. The firm operates from San Francisco with additional offices in Seoul and Yongin, reflecting a cross-border strategy between North America and Asia. Its wealth origin traces to the healthcare and pharmaceutical sector, though specific principals are not publicly disclosed. The firm focuses on direct investments and strategic partnerships in biotech, pharmaceuticals, and healthcare services. Known holdings include positions in cell and gene therapy companies and diagnostic platforms, primarily in South Korea and the United States. Green Cross LabCell engages in both early-stage and growth-stage opportunities, often co-investing alongside institutional partners. Its portfolio targets therapeutic areas such as oncology and rare diseases. Team size and total deployment are not publicly available. The firm maintains a lean structure, with senior professionals drawn from the biotech and finance sectors. An additional office in Yongin supports operational oversight of portfolio companies in South Korea. The firm is part of a broader ecosystem that includes Green Cross Holdings' philanthropic foundations and operating companies. Green Cross LabCell's structural differentiator is its integration with a major Asian healthcare conglomerate, providing unique proprietary deal flow in biotech. This hybrid model combines family-office capital with operational expertise from its parent, enabling deeper due diligence and long-term holding periods. Its cross-border presence also bridges US and Asian markets, a rare positioning among family offices.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Seoul, South Korea · Yongin, South Korea
Sector focus
Frequently asked questions
Who runs investment decisions at Green Cross LabCell Corporation?
Green Cross LabCell does not publicly disclose its investment committee or individual decision-makers. Based on public records, the firm is linked to the Green Cross group, and senior professionals likely hold backgrounds in biotech and finance.
How does Green Cross LabCell source proprietary deal flow?
The firm benefits from its connection to Green Cross Holdings, a South Korean healthcare conglomerate. This provides access to proprietary deal flow in biotech and pharma, particularly in cell and gene therapy, oncology, and diagnostics.
Is Green Cross LabCell structured as a single family office or does it operate more like a venture firm?
Green Cross LabCell operates as a family office focused on direct investments, but its structure mirrors a strategic venture arm due to its ties to Green Cross Holdings. It targets both early-stage and growth-stage healthcare companies.
What investment stages does Green Cross LabCell typically target?
The firm invests across stages, from early-stage biotech startups to growth-stage companies. It prefers direct equity stakes and often participates in syndicated rounds alongside institutional co-investors.
Which sectors does Green Cross LabCell explicitly avoid?
Green Cross LabCell does not publicly disclose excluded sectors. However, based on its healthcare focus, it likely avoids non-life-sciences industries such as real estate, consumer goods, and technology outside biotech.
Where does the underlying wealth come from?
The wealth underlying Green Cross LabCell originates from the Green Cross group, a South Korean pharmaceutical and healthcare conglomerate founded in 1967. The firm is a family office managing the capital of the founding family.
Does Green Cross LabCell maintain philanthropic structures, and how are they separated?
Green Cross Holdings, the parent conglomerate, operates philanthropic foundations. Green Cross LabCell's investment activities are separate from these charitable entities, focusing exclusively on for-profit healthcare investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: